Overview

Clinical Trial of YY1201 for Treatment of Osteoarthritis of the Knee

Status:
Withdrawn
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blinded, parallel, placebo-controlled, phase I/IIa clinical trial of YY1201 for treatment of osteoarthritis of the knee.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Yooyoung Pharmaceutical Co., Ltd.
Yooyoung Pharmaceutical Co.,Ltd.